STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS REXAM ANNUAL REPORT 2014 115 10 DISCONTINUED OPERATIONS CONTINUED iv Cash flows 2014 2013 m m Net cash flows from operating activities 22 50 Net cash flows from investing activities 9 45 Net cash flows from financing activities 5 Net cash outflow inflow 31 10 v Other comprehensive loss 2014 2013 m m Exchange differences 16 9 Exchange differences recognised in the income statement on disposal of Healthcare 152 Total other comprehensive loss 168 9 11 EQUITY DIVIDENDS 2014 2013 m m Interim dividend for 2014 of 5.8p paid on 18 September 2014 41 Final dividend for 2013 of 11.7p paid on 3 June 2014 92 Interim dividend for 2013 of 5.7p paid on 11 September 2013 45 Final dividend for 2012 of 10.2p paid on 22 May 2013 80 133 125 A final dividend per equity share of 11.9p has been proposed for 2014 and, subject to shareholder approval, is payable on 27 May 2015.
The cost of the proposed dividend would be 83m.
The proposed final dividend has not been accrued in these consolidated financial statements.
12 GOODWILL i Summary 2014 2013 m m Cost At 1 January 1,235 1,556 Exchange differences 14 9 Transfer to assets classified as held for sale 330 At 31 December 1,221 1,235 Accumulated impairment At 1 January 3 3 Exchange differences At 31 December 3 3 Carrying value at 31 December 1,218 1,232 The carrying value of goodwill at 31 December is allocated to cash generating units or groups of cash generating units CGUs as set out below.
